Applications published 1 April 2009

Wound care treatment product
Sano Medical BVBA 2040669*

Stable aerosol pharmaceutical formulations
Medispray Laboratories 2040670*

Aqueous suspensions of TMC278
Tibotec Pharmaceuticals 2040671*

Enhanced stability phenylephrine liquid compsns
Wyeth 2040672*

Methods and compsns for treating post-myocardial infarction damage
Abbott Cardiovascular Systems 2040673*

Cationic liposomal preparations for the treatment of rheumatoid arthritis
MediGene; Ludwig-Maximilians-Universitaet 2040674*

Nanoparticulate posaconzole formulations
Elan Pharma International 2040675*

Orally dissolving formulations of memantine
Forest Laboratories 2040676*

Improvements relating to anti-parasitic compsns
Unilever 2040677*

Improvements relating to biocidal compsns
Unilever 2040678*

Preparation of nanodispersions
Unilever 2040679*

Improvements relating to pharmaceutical compsns
Unilever 2040680*

Improvements relating to pharmaceutical compsns
Unilever 2040681*

Microcapsules with improved shells
Ocean Nutrition Canada 2040682*

Pharmaceutical compsns containing a tetrahydrofolic acid
Bayer Schering Pharma Aktiengesellschaft 2040683*

Multiple unit tablets
Lek Pharmaceuticals 2040694*

Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
Flamel Technologies 2040685*

Methods of using a thiazole derivative
Otsuka Pharmaceutical 2040686*

Anaesthetic compsn for topical administration comprising lidocaine, prilocaine and tetracaine
Bouffard Fita 2040687*

New CXCR inhibitors
Sanofi-Aventis 2040688*

• Solution and method to reduce, treat and/or prevent oxidative stress and cell activation
Gambro 2040689*

• Inhibitors of CXCR2
Sanofi-Aventis 2040690*

• Aqueous pharmaceutical formulations of 4-[((4-carboxybutyl)-2-[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoic acid
Bayer HealthCare 2040691*

• Medical use of N-phenylpropenoyl-amino acid derivatives and related compounds
Westfaelische Wilhelms-Universitaet Muenster 2040692*

• Transdermal delivery of oleocanthal for relief of inflammation
Kimberley-Clark Worldwide 2040693*

• Use of PPAR-alpha agonists to treat skeletal muscle wasting disorders
VIB vzw 2040694*

• Methods for the formulation and manufacture of artesunic acid for injection
Walter Reed Army Institute of Research, a Research Laboratory Owned and Operated by the USA, as represented by the Secretary of the Army 2040695*

• Compsns and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
DSM IP Assets 2040696*

• Polymorphic form of duloxetine hydrochloride
Ranbaxy Laboratories 2040697*

• Oxime compounds and the use thereof
Shionogi; Euro-Celtique 2040698*

• Methods and compsns for diagnostic and therapeutic targeting of COX-2
Vanderbilt University Medical Centre 2040699*

• N-(phenylmethyl)-2-(iH-pyrazol-4-yl) acetamide derivatives as P2XY antagonists for the treatment of pain, inflammation and neurodegeneration
Glaxo Group 2040700*

• Aminoindazole urea derivatives
Merck Patent 2040701*

• Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compsns comprising them
Merck Patent 2040702*

• Derivatives of 2-benzoyl-imidazo-pyridines, preparation method thereof and use of same in therapeutics
Sanofi-Aventis 2040703*

• Pharmaceutical compsns comprising implitapide and methods of same
Bayer HealthCare 2040704*

• Use of 2-benzoyl-imidazopyridines in therapeutics
Sanofi-Aventis 2040705*

• Modulators of muscarinic receptors
Vertex Pharmaceuticals 2040706*

• Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
Nycomed 2040707*

• Quercetin-containing compsns
Lines, Thomas Christian 2040708*

• Selective androgen receptor modulators, analogs and derivatives thereof and uses therefor
Osurf; The University of Tennessee Research Foundation 2040709*

• Novel polymorph of esomeprazole potassium and process for its preparation
Glenmark Pharmaceuticals 2040710*

• 2-oxo-1,2-dihydroquinoline derivatives, compsns and uses thereof as antiproliferative agents
Amphora Discovery 2040711*

• Carbonate and carbamate pro-drugs of thiazolo [4,5-D] pyrimidines
Anadys Pharmaceuticals 2040712*

• Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions
Intercept Pharmaceuticals 2040713*

• Method for the eradication of pathogens comprising generating molecular iodine in situ
BioCide Pharma 2040714*

• Antimicrobial compsn
Sinclair Pharmaceuticals 2040715*

• Cellulose sulphate for the treatment of rhinovirus infection
Marinomed Biotechnologie 2040716*

• Method for enhancing the control of viruses on skin
The Dial Corp 2040717*

• Gallium nitrate formulations
Emisphere Technologies 2040718*

• Use of cells derived from adipose tissue for the preparation of an anti-tumour medicament
Centre National de la Recherche Scientifique; Universite Paul Sabatier Toulouse; Institut National de la Sante et de la Recherche Medicale 2040719*

• Method for the detection and neutralisation of bacteria
KCI Licensing 2040720*

• Medicinal compsns containing honey
Medihoney 2040721*